BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 11129230)

  • 1. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report.
    Azuma T; Hirai M; Ito S; Yamamoto K; Taggart RT; Matsuba T; Yasukawa K; Uno K; Hayakumo T; Nakajima M
    Int J Cancer; 1996 Aug; 67(4):492-7. PubMed ID: 8759606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
    Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
    Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
    Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
    Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology.
    Märten A; Büchler MW; Werft W; Wente MN; Kirschfink M; Schmidt J
    J Immunother; 2010; 33(2):219-24. PubMed ID: 20139773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
    Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
    Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].
    Zhang Y; Ji SR; Feng DX; Ji J; Han TQ
    Ai Zheng; 2003 Mar; 22(3):295-7. PubMed ID: 12654190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
    Lu X; Xu T; Qian J
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer.
    Joergensen MT; Heegaard NH; Schaffalitzky de Muckadell OB
    Pancreas; 2010 Mar; 39(2):243-7. PubMed ID: 19820423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
    Nakashima A; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Oda M; Sueda T; Hiyama E
    Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.